CASI Pharmaceuticals, Inc. financial data

Symbol
CASI on Nasdaq
Industry
Pharmaceutical Preparations
Location
1701 1702, China Central Office Tower 1, No. 81 Jianguo Road, Chaoyang District, Beijing, China
State of incorporation
Cayman Islands
Fiscal year end
December 31
Former names
CASI Pharmaceuticals Holdings, Inc. (to 2/14/2023)
Latest financial report
20-F - Q4 2024 - Mar 31, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.5M shares +15.8%
Common Stock, Shares, Outstanding 15.5M shares +15.8%
Common Stock, Value, Issued 2K USD +100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.5M USD -21.2%
Accounts Receivable, after Allowance for Credit Loss, Current 15.3M USD +60.7%
Inventory, Net 5.25M USD -66.9%
Assets, Current 39.6M USD -33.3%
Property, Plant and Equipment, Net 7.87M USD -14.9%
Operating Lease, Right-of-Use Asset 3.49M USD +46%
Intangible Assets, Net (Excluding Goodwill) 238K USD -87.1%
Other Assets, Noncurrent 587K USD -23.4%
Assets 53.7M USD -28.7%
Accounts Payable, Current 2.72M USD -38.6%
Liabilities, Current 36.5M USD +118%
Operating Lease, Liability, Noncurrent 2.54M USD +56.9%
Other Liabilities, Noncurrent 15.4M USD -0.72%
Liabilities 51.8M USD +1.41%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.77M USD -47.8%
Retained Earnings (Accumulated Deficit) -700M USD -5.94%
Stockholders' Equity Attributable to Parent 1.85M USD -92.3%
Liabilities and Equity 53.7M USD -28.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 15.9M shares +15.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 62.5M USD +1.93%
Operating Lease, Liability 3.76M USD +60.2%
Lessee, Operating Lease, Liability, to be Paid 4.03M USD +56%
Property, Plant and Equipment, Gross 13.6M USD -2.28%
Operating Lease, Liability, Current 1.22M USD +67.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.24M USD +145%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.34M USD +84.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 273K USD +14.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 854K USD +120%
Deferred Tax Assets, Operating Loss Carryforwards 48.5M USD +14.1%
Unrecognized Tax Benefits 558K USD -41.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 340K USD -2.86%
Additional Paid in Capital 713M USD +2.52%
Deferred Tax Assets, Net of Valuation Allowance 937K USD +38.4%